BridgeMD
New treatment option for Brain Cancer
Official title HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
ClinicalTrials.gov ID: NCT06930846
What this study is testing
- What it's testing
- The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-CA, to improve the quality of life and cognitive function in Service Members, Veterans and civilians who are survivors of brain cancer or a brain tumor (CA participants). This study will also assess the ability of the HOBSCOTCH-CA program to improve quality of life in caregivers of patients with brain cancer/tumor and to reduce caregiver burden.
- Time commitment: about 6 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- CA Participants will be referred to the study by their providers (Oncologist) who will be made aware of the study and inclusion/
You likely can't join if
- . Inclusion Criteria 2. - 5. and Exclusion Criteria 1. - 3. will be confirmed by referring providers. Participants who learn about the study here and...
- 18 + years
- Service members, Veterans and civilians with a diagnosis of brain cancer (excluding glioblastoma)
- Diagnosis of primary brain tumor with expected survival of 2 years or greater (e.g., low-grade glioma, oligodendroglioma, IDH mutant astrocytoma...
- Patients undergoing surgical and/or radiation therapy will have completed their treatment at least 3 months prior to being enrolled in trial (Note...
- Stable on all CNS acting medications for one month prior to enrollment
See the full eligibility criteria
- CA Participants will be referred to the study by their providers (Oncologist) who will be made aware of the study and inclusion/
- . Inclusion Criteria 2. - 5. and Exclusion Criteria 1. - 3. will be confirmed by referring providers. Participants who learn about the study here and elsewhere will be instructed on how to confirm their eligibility with...
- 18 + years
- Service members, Veterans and civilians with a diagnosis of brain cancer (excluding glioblastoma)
- Diagnosis of primary brain tumor with expected survival of 2 years or greater (e.g., low-grade glioma, oligodendroglioma, IDH mutant astrocytoma, meningioma) defined as the presence of a primary lesion on neuroimaging...
- Patients undergoing surgical and/or radiation therapy will have completed their treatment at least 3 months prior to being enrolled in trial (Note: patients receiving chemotherapy or other systemic therapy will be...
- Stable on all CNS acting medications for one month prior to enrollment
- Subjective cognitive complaints
- Literate and proficient in English
- Internet access for the pre-session and Session 1 of the HOBSCOTCH-CA program; telephone access for sessions 2-8 Exclusion Criteria for CA Participant:
- Presence of a neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease)
- Acute psychiatric disorder or substance abuse
- Patients with glioblastoma (GBM) Inclusion Criteria for CA Participant Caregiver:
- Age 18 +
- Caregiver to a patient with a confirmed diagnosis of brain cancer/tumor survivor
- CA Subject has given permission for their caregiver to participate
- Literate and proficient in English
- Internet access (for Pre-HOBSCOTCH and Session 1)
- Telephone access (for Session 8) Exclusion Criteria for CA Participant Caregiver:
- Significant visual impairment precluding reading or writing
- No reliable telephone or internet access
The study team makes the final eligibility decision.
Where it's taking place
- Lebanon, New Hampshire, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lebanon, New Hampshire, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.